Newswise — Boston – A drug that simultaneously strikes cancer cells’ growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with…
Read more Dual-action drug produces positive results in patients with advanced neuroendocrine tumors, trial findsNewswise — Boston – Belzutifan significantly reduced the risk of progression of clear cell renal cell carcinoma (ccRCC), the most common type of kidney cancer, in patients previously…
Read more Kidney cancer study shows improved outcomes for patients with advanced disease when treated with belzutifan over everolimusNewswise — Boston – The Pancreatic Cancer Action Network (PanCAN), a leading non-profit in the fight against pancreatic cancer, has awarded Dana-Farber Cancer Institute researchers William Freed-Pastor, MD,…
Read more Pancreatic cancer research in vaccines, immune-based therapies and KRAS inhibition funded by The Pancreatic Cancer Action NetworkRESEARCH SUMMARY Study Title: Early Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer Publication: Journal of Clinical Oncology Dana-Farber Cancer Institute authors: Jeremiah Wala; MD, PhD, Paul Nguyen, MD,…
Read more Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer guided by Dana-Farber case studyRESEARCH SUMMARY Publication: Nature Genetics https://www.nature.com/articles/s41588-023-01307-z Dana-Farber Cancer Institute author: Cigall Kadoch, PhD, Summary: A new class of oral drugs can inhibit a wide range of SARS-CoV-2…
Read more New Class of Drugs May Prevent Infection by Wide Range of COVID-19 VariantsRESEARCH SUMMARY Study Title: An atlas of substrate specificities for the human serine/threonine kinome Publication: Nature (Online) January 11, 2023 https://www.nature.com/articles/s41586-022-05575-3 Dana-Farber Cancer Institute author: Lewis C. Cantley,…
Read more Study Links Key Activating Enzymes to Specific Sites on Proteins in CellsNewswise — BOSTON –A combination of two next-generation immunotherapy drugs has shown promising clinical activity in treating patients with refractory metastatic colorectal cancer, a disease which has not…
Read more Immunotherapy with two novel drugs shows activity in colorectal cancerNewswise — Every year, up to 1% of patients with chronic lymphocytic leukemia (CLL), a slow-growing blood cancer, have their disease transform into a far more aggressive cancer,…
Read more Scientists Map Genetic Evolution of Chronic Lymphocytic Leukemia to Richter’s Syndrome
